HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Earnings In Brief

This article was originally published in The Rose Sheet

Executive Summary

IFF: North American fragrance sales grew 8% on functional fragrance and aroma chemical sales in Q2, flavors and fragrance manufacturer reports July 29. Fine fragrance sales declined 1%, however. Total revenue in the region was up 7%. Worldwide net sales grew 9% to $524.2 mil., benefiting from a weakening of the U.S. dollar. At constant exchange rates, Q2 sales grew 5%, the firm says. Net income was up 10% to $56.5 mil. Results include $7.7 mil., or $5 mil. after tax, charges related to restructuring and "the impairment of certain European fruit business assets," as well as the closure of the firm's Canadian manufacturing facility. At current exchange rates, reported sales are expected to be in high single digits for the year...

Latest Headlines
See All
UsernamePublicRestriction

Register

RS012337

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel